Barrett Elizabeth A.

Barrett Elizabeth A. is listed in filings as Chief Executive Officer at UroGen Pharma Ltd.. This profile follows SEC Form 4 activity through Feb 19, 2026, including 7 public disclosures. Recent filings connect the profile to UroGen Pharma Ltd. (URGN), Sage Therapeutics, Inc. (SAGE), and Allogene Therapeutics, Inc. (ALLO). The current snapshot covers public activity from Feb 4, 2025 to Feb 19, 2026. Reported amounts are shown as $145.6K to $10.5K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.